Seoul — October 27, 2026. Published after the market close; equity index and stock prices are official closing values (currency levels are indicative late-session quotes).

The 30-second version
- The KOSPI closed at 5,638.34, up 3.09%, after briefly rising more than 4% intraday — a move sharp enough to trigger a buy-side "sidecar," the 26th this year.
- The KOSDAQ followed, closing up 2.29% at 743.83.
- The spark came from overnight New York trading: the Philadelphia Semiconductor Index (SOX) jumped 2.82%, with the Nasdaq up 0.83% and the S&P 500 up 0.70%.
- Foreign and institutional investors were net buyers; retail investors net sold 949.3 billion won (about $717 million) on the KOSPI — classic profit-taking into a spike.
- The Bank of Korea reported Q3 GDP growth of +1.0% quarter-on-quarter, beating expectations.
- The big outlier: Samsung Biologics fell 5.18% on a prolonged labor dispute.
A rally imported from New York — with a built-in speed bump
Today’s surge was not a homegrown story. It was momentum carried over from the previous US session (October 26, local time), where AI and semiconductor names rallied hard — the SOX chip index alone gained 2.82%. When Seoul opened, Korea’s chip-heavy large caps simply picked up where New York left off.
The buying was so concentrated that at 10:13 a.m. the exchange triggered a buy-side sidecar — the 26th of the year. For readers unfamiliar with the mechanism: a sidecar is a milder cousin of the circuit breaker. Instead of halting all trading, it pauses program buy orders (large algorithmic basket trades) for five minutes when futures spike sharply. Think of it as a speed bump for the machines, not a roadblock for the market. Trading in individual stocks continues throughout.
The leadership was unmistakably semiconductor and electronics. By sector, electrical and electronics gained 4.48%, medical and precision instruments 4.30%, manufacturing 3.52%, machinery 2.26%, and financials 2.18%. Among large caps, Samsung Electro-Mechanics rose 7.42%, SK Square 6.70%, Samsung SDI 4.96%, SK hynix 4.26%, and Samsung Electronics 3.75%. On the KOSDAQ, chip-equipment and testing names such as TFE (+22.90%), Exicon (+21.98%), Micro Contact Solution (+18.59%), and Okins Electronics (+17.47%) rode the same wave — a trickle-down effect from the large-cap rally.
Who was buying — and who was cashing out
The flow data tells a clean story. On the KOSPI, foreign investors net bought 591.1 billion won (roughly $446 million) and institutions added 282.0 billion won (about $213 million). Retail investors went the other way, net selling 949.3 billion won — more than the foreign and institutional buying combined (873.1 billion won, or about $659 million).
The same pattern, in miniature, played out on the KOSDAQ: institutions net bought 150.2 billion won and foreigners 19.1 billion won, while retail sold 165.9 billion won. This is the textbook shape of a sharp up-day in Korea: professional money chases the momentum, and individual investors use the strength to lock in gains. It also means the rally was absorbed against meaningful selling pressure — worth remembering if US chip sentiment wobbles.
The won barely moved. The dollar traded at around 1,324 won late in the session, with the won down about 0.2% — no sign of stress in the currency despite the risk-on equity session. (Dollar conversions in this post use that approximate rate.)
A GDP beat, one big loser, and the speculative fringe
The macro backdrop helped. The Bank of Korea’s advance estimate put Q3 real GDP growth at +1.0% quarter-on-quarter, above market expectations, with exports still growing and facilities investment rebounding 4.1%. That gave the imported chip rally a domestic fundamental anchor rather than leaving it purely a sentiment trade.
The glaring exception among large caps was Samsung Biologics, which fell 5.18% — the only major decliner of its size on the day. The cause is a drawn-out labor dispute over pay and personnel policy. The union postponed a planned second general strike but passed a strike-fund resolution by member vote, keeping the standoff alive. For a contract drug manufacturer (CMO), the market’s worry is straightforward: anything that threatens on-time delivery threatens the trust the whole business model rests on. A few financial and biotech names left out of the chip rally also slipped, including KB Financial (-0.40%) and Celltrion (-0.74%).
Two caution flags on the KOSDAQ fringe. First, several of the day’s biggest gainers — Melcon (+32.36%) and Global Technology (+27.66%) among them — rose without any confirmed disclosure or earnings catalyst; these look like short-term money chasing momentum. Second, the decliner list was brutal at the bottom: Softsen preferred shares fell 69.97% and Seoul Food preferred 34.87%. These are mostly low-priced, preferred, or administrative-watch issues where boom-bust cycles are routine, and no disclosure-based explanation was identified for the drops either. Both lists are reminders that even on a broad up-day, the speculative edge of this market moves on flows, not fundamentals.
Key closing numbers
| Item | Close | Change |
|---|---|---|
| KOSPI | 5,638.34 | +3.09% |
| KOSDAQ | 743.83 | +2.29% |
| USD/KRW (indicative, late session) | ~1,324 | about +0.2% (won slightly weaker) |
| KOSPI foreign net flow | +591.1bn won (~$446M) | Net buy |
| KOSPI institutional net flow | +282.0bn won (~$213M) | Net buy |
| KOSPI retail net flow | -949.3bn won (~$717M) | Net sell |
| Samsung Electronics | — | +3.75% |
| SK hynix | — | +4.26% |
| Samsung Biologics | — | -5.18% |
What to watch next
- US chip momentum. Today’s rally was largely borrowed from New York. If the SOX reverses, Seoul’s chip complex is the first place the hangover shows up.
- Retail selling pressure. Individual investors sold more than foreigners and institutions bought on the KOSPI. If institutional demand pauses, that overhang matters.
- Samsung Biologics labor dispute. The strike was postponed, not resolved. Watch for further union votes or any sign the conflict touches production schedules.
- The speculative small-cap churn. Several KOSDAQ names moved 20-70% in a single session without confirmed news — a signal of hot, fast money in the system.
FAQ
What is a sidecar in the Korean stock market?
A sidecar is an automatic cooling mechanism that pauses program (algorithmic basket) buy or sell orders for five minutes when index futures move sharply. Unlike a circuit breaker, it does not halt trading in individual stocks. Today’s buy-side sidecar fired at 10:13 a.m. and was the 26th of 2026.
Why did the KOSPI rise 3% on October 27, 2026?
An overnight US semiconductor rally — the SOX index gained 2.82% — flowed directly into Korea’s chip-heavy large caps, with Samsung Electronics up 3.75% and SK hynix up 4.26%. A stronger-than-expected Q3 GDP print (+1.0% quarter-on-quarter) reinforced the move.
Who was buying Korean stocks today?
Foreign investors (+591.1bn won) and institutions (+282.0bn won) on the KOSPI, with a similar pattern on the KOSDAQ. Retail investors were heavy net sellers on both markets, taking profits into the surge.
Why did Samsung Biologics fall while the market rallied?
A prolonged labor dispute. The union postponed a second general strike but approved a strike fund, and investors worry that sustained conflict could undermine the delivery reliability central to its contract-manufacturing (CMO) business.
Disclaimer: This is an information and analysis publication, not investment advice. See our Methodology for data sources, standards, and our corrections policy.
Also on Seoul Closing Bell
A companion piece on the same session, written from a different angle: Retail Investors Sold the KOSPI Rally as Foreigners Bought.
